Transcranial magnetic stimulation (TMS) effects on testosterone, prolactin, and corticosterone in adult male rats. 2002

Dawson W Hedges, and David L Salyer, and Brian J Higginbotham, and Trent D Lund, and James L Hellewell, and David Ferguson, and Edwin D Lephart
Department of Psychology and the Neuroscience Center, Brigham Young University, Provo, Utah 84602, USA.

BACKGROUND Transcranial magnetic stimulation is a relatively new technique for inducing small, localized, and reversible changes in living brain tissue. Although transcranial magnetic stimulation generally results in no immediate changes in plasma corticosterone, prolactin, and testosterone, it normalizes the dexamethasone suppression test in some depressed subjects and has been shown to attenuate stress-induced increases in adrenocorticotropic hormone in rats. METHODS In this study, serum corticosterone and testosterone concentrations were assayed in male rats immediately and 3, 6, 9, 12, 24, and 48 hours following a single transcranial magnetic stimulation or sham application. Serum prolactin concentrations were determined immediately and 2 hours following a one-time application of either transcranial magnetic stimulation or sham. RESULTS Transcranial magnetic stimulation animals displayed significantly lower corticosterone concentrations at 6 and 24 hours following a single application compared with sham-control values. Transcranial magnetic stimulation also resulted in lower corticosterone concentrations numerically but not statistically in transcranial magnetic stimulation animals immediately after application (p =.089). No significant differences were found between groups for serum prolactin or testosterone levels at any given collection time point. CONCLUSIONS These findings 1) suggest that transcranial magnetic stimulation alters the hypothalamic-pituitary-adrenal stress axis and 2) provide time-course data for the implications of the hormonal mechanism that may be involved in the actions of transcranial magnetic stimulation.

UI MeSH Term Description Entries
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D008297 Male Males
D010913 Pituitary-Adrenal System The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. Pituitary Adrenal System,Pituitary-Adrenal Systems,System, Pituitary-Adrenal,Systems, Pituitary-Adrenal
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D004574 Electromagnetic Fields Fields representing the joint interplay of electric and magnetic forces. Electromagnetic Field,Field, Electromagnetic,Fields, Electromagnetic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001143 Arousal Cortical vigilance or readiness of tone, presumed to be in response to sensory stimulation via the reticular activating system. Vigilance, Cortical,Arousals,Cortical Vigilance
D013739 Testosterone A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. 17-beta-Hydroxy-4-Androsten-3-one,17-beta-Hydroxy-8 alpha-4-Androsten-3-one,8-Isotestosterone,AndroGel,Androderm,Andropatch,Androtop,Histerone,Sterotate,Sustanon,Testim,Testoderm,Testolin,Testopel,Testosterone Sulfate,17 beta Hydroxy 4 Androsten 3 one,17 beta Hydroxy 8 alpha 4 Androsten 3 one,8 Isotestosterone
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Dawson W Hedges, and David L Salyer, and Brian J Higginbotham, and Trent D Lund, and James L Hellewell, and David Ferguson, and Edwin D Lephart
December 1995, The Australian and New Zealand journal of psychiatry,
Dawson W Hedges, and David L Salyer, and Brian J Higginbotham, and Trent D Lund, and James L Hellewell, and David Ferguson, and Edwin D Lephart
November 2021, Reviews in the neurosciences,
Dawson W Hedges, and David L Salyer, and Brian J Higginbotham, and Trent D Lund, and James L Hellewell, and David Ferguson, and Edwin D Lephart
June 2019, Experimental oncology,
Dawson W Hedges, and David L Salyer, and Brian J Higginbotham, and Trent D Lund, and James L Hellewell, and David Ferguson, and Edwin D Lephart
August 2015, The Cochrane database of systematic reviews,
Dawson W Hedges, and David L Salyer, and Brian J Higginbotham, and Trent D Lund, and James L Hellewell, and David Ferguson, and Edwin D Lephart
October 2006, Nihon rinsho. Japanese journal of clinical medicine,
Dawson W Hedges, and David L Salyer, and Brian J Higginbotham, and Trent D Lund, and James L Hellewell, and David Ferguson, and Edwin D Lephart
December 2001, Rinsho shinkeigaku = Clinical neurology,
Dawson W Hedges, and David L Salyer, and Brian J Higginbotham, and Trent D Lund, and James L Hellewell, and David Ferguson, and Edwin D Lephart
February 2018, Current psychiatry reports,
Dawson W Hedges, and David L Salyer, and Brian J Higginbotham, and Trent D Lund, and James L Hellewell, and David Ferguson, and Edwin D Lephart
January 2009, B-ENT,
Dawson W Hedges, and David L Salyer, and Brian J Higginbotham, and Trent D Lund, and James L Hellewell, and David Ferguson, and Edwin D Lephart
November 2010, Rinsho shinkeigaku = Clinical neurology,
Dawson W Hedges, and David L Salyer, and Brian J Higginbotham, and Trent D Lund, and James L Hellewell, and David Ferguson, and Edwin D Lephart
February 2009, Physiology & behavior,
Copied contents to your clipboard!